|Mr. Albert G. White III||Pres, CEO & Director||N/A||N/A||1970|
|Mr. Daniel G. McBride Esq.||Chief Operating Officer, Exec. VP and Pres of CooperVision Inc||1.01M||4.03M||1964|
|Mr. Agostino Ricupati||Sr. VP of Fin. & Tax and Chief Accounting Officer||524.37k||83.23k||N/A|
|Mr. Brian Andrews||Sr. VP, CFO & Treasurer||N/A||N/A||N/A|
|Mr. Kim Duncan||VP of Investor Relations & Admin.||N/A||N/A||N/A|
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
The Cooper Companies, Inc.’s ISS Governance QualityScore as of January 1, 2019 is 2. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 3; Compensation: 3.